Alan brings over 20 years of experience guiding startups through growth into leading public companies, particularly in technology, biotechnology, and medical devices. He assists clients at every stage, from early funding to capital raises and exit opportunities. For example, Alan’s work with Smartsheet spans from its inception to its IPO and beyond, continuing to support the company in its public life and most recently in its $8.4 billion acquisition by Blackstone and Vista Equity Partners. Similarly, his guidance of Redfin started with their Series A and continues beyond the IPO, advising the company on ongoing public company matters, and most recently in its $1.75 billion acquisition by Rocket Companies.

Recognized as one of the nation’s leading lawyers for corporate, M&A, capital markets, securities, and venture capital, Alan also assists companies with regulatory compliance, employee relations, and governance requirements. He serves as chair of Fenwick’s corporate group.

Alan dives deep into a range of technologies, including e-commerce, hardware, software/SaaS and cloud computing, mobile and wireless, data storage, and consumer products.

He also represents biotech companies developing therapeutics for oncology, immunological, neurological, and other indications, and medical device companies pursuing cardiac, neurological, and surgical indications, and diagnostics and drug delivery devices.